CSF2 and prostate cancer: In metastatic hormone refractory prostate cancer (HRPC), allogeneic prostate cancer cell lines engineered to secrete GM-CSF (GVAX-PCa) were found to be well tolerated and improve anti-cancer immune responses (104).